The above results clearly indicate that Aurora-A contributes to cisplatin resistance by inhibiting cell senescence and promoting glycolysis through regulation of the SOX8/FOXK1 signaling pathway in ovarian cancer. This evidence concerns the gene SOX8 and ovarian carcinoma.